Literature DB >> 25136256

Ulcerative colitis and Crohn's disease.

Kunj Gohil, Brielle Carramusa.   

Abstract

As new drugs emerge from the pipeline for the nearly 2 billion patients globally diagnosed with ulcerative colitis and Crohn's disease, sales of therapies for these conditions are expected to increase from $7.35 billion today to $11.05 billion in 2022.

Entities:  

Year:  2014        PMID： 25136256      PMCID： PMC4123809     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  7 in total

1.  INFLAMMATORY BOWEL DISEASES: CHARACTERISTICS, EVOLUTION, AND QUALITY OF LIFE.

Authors:  Caique Moraes Mendonça; Isaac José Felippe Correa Neto; Alexander de Sá Rolim; Laercio Robles
Journal:  Arq Bras Cir Dig       Date:  2022-06-17

2.  Temporal induction of intestinal epithelial hypoxia-inducible factor-2α is sufficient to drive colitis.

Authors:  Sumeet Solanki; Samantha N Devenport; Sadeesh K Ramakrishnan; Yatrik M Shah
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-06-26       Impact factor: 4.052

3.  Declining use of combination infliximab and immunomodulator for inflammatory bowel disease in the community setting.

Authors:  Joshua C Berkowitz; Joanna Stein-Fishbein; Sundas Khan; Richard Furie; Keith S Sultan
Journal:  World J Gastrointest Pharmacol Ther       Date:  2018-02-06

4.  Pharmacological inhibition of NPY receptors illustrates dissociable features of experimental colitis in the mouse DSS model: Implications for preclinical evaluation of efficacy in an inflammatory bowel disease model.

Authors:  Henry H Ruiz; Stephanie Becker; Yu Bai; Luz A Cortes-Burgos; Melissa M Eckersdorff; Lynn E Macdonald; Susan D Croll
Journal:  PLoS One       Date:  2019-08-01       Impact factor: 3.240

Review 5.  Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders.

Authors:  Alexander Markov; Lakshmi Thangavelu; Surendar Aravindhan; Angelina Olegovna Zekiy; Mostafa Jarahian; Max Stanley Chartrand; Yashwant Pathak; Faroogh Marofi; Somayeh Shamlou; Ali Hassanzadeh
Journal:  Stem Cell Res Ther       Date:  2021-03-18       Impact factor: 6.832

Review 6.  Immunomodulatory Mechanisms of Mesenchymal Stem Cells and Their Potential Clinical Applications.

Authors:  Yutong Huang; Qiang Wu; Paul Kwong Hang Tam
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

Review 7.  Gastrointestinal and renal complications in SARS-CoV-2-infected patients: Role of immune system.

Authors:  Fatemeh Maghool; Ali Valiani; Tahereh Safari; Mohammad Hassan Emami; Samane Mohammadzadeh
Journal:  Scand J Immunol       Date:  2020-12-07       Impact factor: 3.889
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.